Logo Image
News
Watch
Expert ConversationsNews & Analysis
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Monica Morrow, MD

Advertisement

Articles by Monica Morrow, MD

Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology

BySusan M. Gapstur, PhD, MPH,Monica Morrow, MD,Thomas A. Sellers, PhD,Susan M. Gapstur, PhD, MPH,Monica Morrow, MD,Thomas A. Sellers, PhD,Susan M. Gapstur, PhD, MPH,Monica Morrow, MD,Thomas A. Sellers, PhD
August 2nd 2011

To review, the recent article in the Lancet that he discussed showed that there was a very small increased risk of breast cancer by taking hormones over a prolonged length of time. However, certainly this risk should be viewed in the overall context of risks and benefits.

Advertisement

Latest Updated Articles

  • Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology
    Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology

    August 2nd 2011



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Off-label testosterone dosing, access, and lab monitoring in the US

2

FDA holding public meeting on testosterone use in menopausal women

3

Kevin Ault, MD, on coordinating RSV prevention across maternal and pediatric care

4

Survey: 51% of US-women report negative healthcare experiences

5

Pellet therapy and practical advice for hesitant prescribers

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us